top of page


Insilico Medicine and China Medical System Expand AI Drug Discovery Partnership with $177m CNS Deal
The latest agreement strengthens the companies’ collaboration as they target a major central nervous system indication using AI-powered drug discovery.

nuaxia
Jul 143 min read


AstraZeneca Expands China Partnerships with Up to $2.1bn Respiratory Drug Deal
The agreement with Sino Biopharmaceutical gives AstraZeneca ex-China rights to TQC3721, an experimental dual PDE3/4 inhibitor being developed for chronic respiratory diseases.

nuaxia
Jul 93 min read


Big Pharma Isn’t Just Buying From China Anymore — It’s Building With It
Bristol Myers Squibb’s expanding partnership strategy signals how China is evolving from a biotech sourcing market into a core pillar of global pharmaceutical R&D

nuaxia
May 152 min read
bottom of page